产品介绍：
产品说明
应用
C16 Dihydroceramide (d18:0/16:0) is suitable for use to study the potential relevance of the changes observed in the sphingolipid composition of autophagosomes and autolysosomes in tetrahydrocannabinol (THC) treated cells or to destabilize biological membranes.
生化/生理作用
Dihydroceramide acts as a precursor for ceramide synthesis. It has an ability to induce autophagy in the perinuclear region. Dihydroceramide affects autophagic flux and enhances the formation lipid droplets. Accumulation of C16-dihydroceramides might lead to liver injury.
包装
5 mL Amber Glass Screw Cap Vial (860634P-10mg)
5 mL Amber Glass Screw Cap Vial (860634P-5mg)
基本信息
| 经验(实验)分子式 | C34H69NO3 |
| 分子量 | 539.92 |
| NACRES | NA.25 |
产品性质
| 形式 | powder |
| 包装 | pkg of 1 × 10 mg (860634P-10mg) pkg of 1 × 5 mg (860634P-5mg) |
| manufacturer/tradename | Avanti Polar Lipids 860634P |
| 运输 | dry ice |
| 储存温度 | −20℃ |
| SMILES string | OC[C@]([H])(NC(CCCCCCCCCCCCCCC)=O)[C@]([H])(O)CCCCCCCCCCCCCCC |
安全信息
| 储存分类代码 | 13 - Non Combustible Solids |
